Sacubitril/valsartan and quality of life assessed using the EQ-5D-3L questionnaire level sum score (LSS) in patients with heart failure across the spectrum of ejection fraction
19 May 2025 (09:12 - 09:21)
Organised by: 

About the speaker

Zhongda Hospital, Southeast University, Nanjing (China)
6 More presentations in this session

Doctor C. Lawson (Leicester, GB)

Doctor J. Hahnle (Cape Town, ZA)
Access the full session
The Event
Heart Failure 2025
19 May 2025
09:12 CET
You may be interested in
Congress Presentation
Congress Presentation





